UK researchers are planning a ‘test-and-treat’ approach to correct people’s vitamin D deficiency to study whether this reduces the risk and/or severity of COVID-19 and other acute respiratory infections.
Led by Queen Mary University of London, the CORONAVIT trial will run for six months and involve more than 5,000 UK citizens aged 16 and above
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?